This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Sofia Strep A FIA Field Study

This study has been terminated.
(Performance did not meet sponsor requirements.)
Information provided by (Responsible Party):
Quidel Corporation Identifier:
First received: December 15, 2011
Last updated: October 5, 2012
Last verified: October 2012
The purpose of this study is to demonstrate the ability of the Sofia Strep A FIA test and Sofia Analyzer to accurately detect a throat swab specimen for the presence or absence of Group A Streptococcus when compared to culture.

Condition Intervention
Group A Streptococcus Strep Throat Device: In Vitro Diagnositc aid for diagnosis

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Sofia Strep A FIA Field Study

Resource links provided by NLM:

Further study details as provided by Quidel Corporation:

Enrollment: 2090
Study Start Date: November 2011
Study Completion Date: August 2012
Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   3 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Subjects must be three (3) years of age or older and exhibiting symptoms characteristics of pharyngitis, possibly Group A Streptococcus.

Inclusion Criteria:

  • Presence of sore throat
  • Redness of the posterior pharyngeal wall
  • Tonsillar exudate
  • Tonsillar swelling
  • Tender anterior cervical adenopathy
  • Fever, > 38º C (100.4ºF) at presentation or within past 24 hours

Other symptoms that may be present, in addition to above symptoms for GAS:

  • Rash, typical of scarlet fever
  • Abnormal tympanic membranes
  • Palatal petechiae

Exclusion Criteria:

  • Subjects treated with antibiotics currently or within the previous week (7 days) are not to be included in this study.
  • At clinical sites requiring informed consent, unable to understand and consent to participation; for minors this includes parent or legal guardian.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01494792

United States, California
La Costa Pediatrics
Carlsbad, California, United States, 92009
Santo Nino Medical Clinic
Panorama City, California, United States, 91402
La Jolla Pediatrics
San Diego, California, United States, 92121
United States, Florida
Teena Hughes, MD
Tampa, Florida, United States, 33613
United States, Illinois
Children's Memorial Hospital
Chicago, Illinois, United States, 60614-3394
United States, New York
Twelve Corners Pediatrics
Rochester, New York, United States, 14618
United States, Ohio
Montrose Family Practice
Akron, Ohio, United States, 44333
United States, Virginia
Advanced Pediatrics
Vienna, Virginia, United States, 22180
Sponsors and Collaborators
Quidel Corporation
  More Information

Responsible Party: Quidel Corporation Identifier: NCT01494792     History of Changes
Other Study ID Numbers: CS-0142-02
Study First Received: December 15, 2011
Last Updated: October 5, 2012 processed this record on September 20, 2017